Arca
Skip to content
Tools
Tools

Warning Letter to Stonegate Pharmacy LP

Drugs. See Stonegate Pharmacy's company page or this site's inspections.

On Apr 24, 2019, FDA's CDER sent Stonegate Pharmacy LP a warning letter.

  • Letter date: Apr 24, 2019
  • Issued by: CDER
  • Closeout: โ€”

The Letter

As posted on FDA.gov โ†—; cited 21 CFR sections link to their page.

Dr. Garza:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firmโ€™s corrective actions in response to our warning letter [2017-DAL-WL-03, dated November 10, 2016]. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDAโ€™s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely, /S/ CDR John W. Diehl, M.S. Director, Compliance Branch Office of Pharmaceutical Quality Operations, Division II

Record

Recipient
Rene F. Garza, PharmD
FDA site ID (FEI)
3012038236
Cited
โ€”

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.